Orris

Acute gastroenteritis for 20 days what is the next step

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

persistent diarrhea evaluation adults

Reading File
Reading File
Reading File

Key point: this is no longer "acute" gastroenteritis

By standard definitions, diarrheal illness is classified as acute (<7 days), prolonged (7-13 days), persistent (14-29 days), or chronic (≥30 days) - Rosen's Emergency Medicine, p. 1301. At 20 days, the correct label is persistent diarrhea/gastroenteritis, not acute gastroenteritis, and this changes both the differential diagnosis and the next steps.
Acute/prolonged gastroenteritis (≤13 days) is usually viral or bacterial and self-limited. Once it crosses into the persistent/chronic range (>13-14 days), the leading causes shift toward protozoa/parasites (Giardia, Cryptosporidium, Entamoeba histolytica), certain bacteria (enteroaggregative E. coli, C. difficile, Shigella, Salmonella), and non-infectious causes (IBD, malabsorption, celiac disease, bile-acid diarrhea, post-infectious IBS, microscopic colitis) - Goldman-Cecil Medicine, p. 1462; Yamada's Textbook of Gastroenterology.

Next step: reassess and work up persistent diarrhea

1. Focused history - travel/exposure history, HIV risk factors, recent antibiotics or hospitalization (risk for C. difficile), immunocompromise, nocturnal symptoms, fever, weight loss, blood/mucus in stool, medication review, family history of GI disease.
2. Exam - hydration status, nutritional status, signs of malabsorption, extraintestinal findings.
3. Labs
  • CBC with differential, electrolytes, renal function, LFTs, serum albumin/total protein
  • Fecal calprotectin (>50 μg/g) or fecal lactoferrin to screen for inflammatory bowel disease (AGA guideline, cited in Yamada's Textbook of Gastroenterology, p. 716)
  • Celiac serology (tissue transglutaminase IgA)
4. Stool studies
  • Stool culture
  • Giardia stool antigen/PCR (or multiplex GI PCR panel covering bacterial, viral, and protozoal pathogens)
  • C. difficile toxin/PCR, especially with recent antibiotic exposure
  • Ova and parasites if travel/exposure history supports it
5. If initial workup is unrevealing (or patient is over 50, or has alarm features like weight loss/bleeding) - colonoscopy with terminal ileal and colonic biopsies; upper endoscopy with biopsy if malabsorption or a proximal process is suspected.
6. Empiric treatment can be reasonable if clinical suspicion is high (e.g., empiric metronidazole/tinidazole for suspected giardiasis after relevant exposure), with response to treatment supporting the diagnosis without further testing - Goldman-Cecil Medicine, p. 1462.
7. Supportive care throughout - oral or IV rehydration, electrolyte correction, and monitoring, since dehydration risk persists regardless of etiology.
Diagnostic yield of routine stool culture alone is low (~2%) in the acute setting, so targeted, exposure-driven testing (rather than a shotgun panel) is preferred once you're in the persistent-diarrhea category - Tintinalli's Emergency Medicine, p. 352.
A 2024 systematic review/meta-analysis on infectious etiologies of persistent and chronic diarrhea (PMID: 38740524) supports this same stepwise approach, particularly the emphasis on protozoal and HIV-related causes in patients with diarrhea beyond 2 weeks - useful to check if you want the most current epidemiologic breakdown.
If you can share more clinical detail (age, travel history, immune status, fever, blood in stool, weight loss, recent antibiotics), I can narrow this down to a more specific differential and testing sequence.

Fecal calprotectin is 379

Finding Sources
Searching PubMed

fecal calprotectin inflammatory bowel disease cutoff

A fecal calprotectin of 379 μg/g is markedly elevated (normal <50 μg/g) and confirms active intestinal mucosal inflammation. This substantially narrows the picture and changes the next step.

What this changes

Fecal calprotectin is a marker of neutrophilic gut inflammation. It's used specifically to distinguish an organic/inflammatory process (IBD, infectious colitis, ischemic colitis, neoplasia) from a functional cause (IBS, post-infectious functional diarrhea) - Symptom to Diagnosis, p. 201; Tietz Textbook of Laboratory Medicine, p. 672. A value this high (>250-300) makes a purely functional diagnosis unlikely and pushes the differential firmly toward:
  • Inflammatory bowel disease (Crohn's disease or ulcerative colitis) - most important to exclude given 20 days of symptoms
  • Infectious colitis (bacterial or protozoal) - calprotectin also rises with active infection, not just IBD
  • Less commonly: ischemic colitis, radiation colitis, or colonic neoplasia

Next step

1. Make sure infection has been ruled out first, if not already done - stool culture, C. difficile toxin/PCR, Giardia antigen/PCR, ova and parasites (or a multiplex GI PCR panel). An elevated calprotectin does not by itself distinguish infection from IBD, so this must be checked before attributing the result to IBD.
2. If infectious workup is negative (or already excluded) → proceed to colonoscopy with ileal intubation and biopsies. This is the definitive next step to evaluate for Crohn's disease or ulcerative colitis given a calprotectin this high plus 20 days of diarrhea. Yamada's Textbook of Gastroenterology recommends colonoscopy with biopsies in patients with unexplained persistent diarrhea, particularly when inflammatory markers are elevated (p. 716).
3. Supporting labs to send alongside/before colonoscopy:
  • CRP and/or ESR
  • CBC (screen for anemia, leukocytosis)
  • Albumin, iron studies (nutritional/inflammatory impact)
  • Consider CT or MR enterography if small bowel Crohn's disease is suspected clinically (e.g., right lower quadrant pain, weight loss)
4. Referral to gastroenterology for the colonoscopy and further management is appropriate at this point rather than continued empiric treatment in primary care.
A 2023 meta-analysis (PMID: 37823411) on fecal calprotectin's diagnostic performance for distinguishing IBD from IBS in adults supports using this kind of elevated value as a strong trigger for endoscopic evaluation rather than presuming a functional diagnosis - consistent with the textbook guidance above.
If you have CRP/ESR, stool infectious studies, or exam findings (weight loss, blood in stool, abdominal pain pattern), sharing those would let me narrow further between Crohn's, UC, and residual infectious causes.
This is a shared conversation. Sign in to Orris to start your own chat.